SP-C Activators

The chemical class of SP-C activators encompasses a diverse array of compounds that can directly or indirectly modulate the activation of surfactant protein C (SP-C). SP-C is a critical component of pulmonary surfactant, playing a pivotal role in reducing surface tension within the alveoli and facilitating proper lung function. While direct activators of SP-C remain elusive, several compounds exhibit the ability to influence its activation through intricate cellular signaling pathways. Among the compounds listed, PPARγ agonists such as troglitazone and rosiglitazone can indirectly activate SP-C by influencing pathways related to adipocyte differentiation and lipid metabolism. The activation of PPARγ orchestrates cellular responses crucial for the synthesis and secretion of surfactant proteins in type II alveolar cells. Additionally, AICAR, an AMPK activator, indirectly impacts SP-C activation by modulating cellular energy status and metabolic pathways, crucial for surfactant protein synthesis.

Histone deacetylase (HDAC) inhibitors, including salubrinal and vorinostat, represent another facet of SP-C activators. By preventing eIF2α dephosphorylation, salubrinal indirectly activates SP-C through enhanced translation of mRNAs encoding surfactant proteins. Vorinostat, on the other hand, influences SP-C activation by altering histone acetylation patterns, leading to chromatin remodeling and increased accessibility of the SP-C gene for transcription. Furthermore, compounds like 9-cis-retinoic acid, betulinic acid, and amlexanox showcase the ability of retinoid receptor agonists, triterpenoids, and kinase inhibitors, respectively, to indirectly modulate SP-C activation by influencing critical cellular pathways involved in surfactant protein synthesis.